Abstract
The present study determined the pharmacological effects of acute morphine treatment on the granulocyte phase of the peritoneal inflammatory response to thioglycollate (TG) in rats. Dual-color flow cytometry using anti-CD11b/c-PE mAb in combination with HIS48-FITC mAb allowed for the determination of morphine's effects on 4 inflammatory cell subsets: CD11b/c+HIS48med granulocytes; CD11b/chiHIS48neg/lo activated macrophages; CD11b/c−HIS48− lymphocytes; and CD11b/c+HIS48hi cells (a monocyte/macrophage and granulocyte subset). Morphine produced a dose-dependent increase in a select subset of inflammatory peritoneal cells, the CD11b/c+HIS48med granulocytes. The effect of morphine was time-dependent, with significant effects first apparent at 4 hr after TG, but the administration of morphine 1 hr before or simultaneously with TG produced a similar increase in CD11b/c+HIS48med granulocytes. Naltrexone completely antagonized the morphine-induced increase in CD11b/c+HIS48med granulocytes. Collectively, these studies show that a single administration of morphine produces a time-dependent, dose-dependent, opioid receptor-mediated enhancement in the peritoneal granulocyte response to TG.
Similar content being viewed by others
REFERENCES
Hung, C. Y., S. S. Lefkowitz, and W. F. Geber. 1973. Interferon inhibition by narcotic analgesics. Proc. Soc. Exp. Biol. Med. 142:106–111.
Lefkowitz, S. S. and C. Y. Chiang. 1975. Effects of certain abused drugs on hemolysin forming cells. Life Sci. 17:1763–1768.
Ho, W. K. K. and A. Leung. 1979. The effect of morphine addiction on concanavalin A-mediated blastogenesis. Pharmacol. Res. Comm. 11:413–419.
Güngör, M., E. Genç, H. Sagduyu, L. Eroglu, and H. Koyuncuoglu. 1980. Effect of chronic administration of morphine on primary immune response in mice. Experientia 36:1309–1310.
Tubaro, E., G. Borelli, C. Croce, G. Cavallo, and C. Santiangeli. 1983. Effect of morphine on resistance to infection. J. Infect. Dis. 148:656–666.
Shavit, Y., A. Depaulis, F. C. Martin, G. W. Terman, R. N. Pechnick, C. J. Zane, R. P. Gale, and J. C. Liebeskind. 1986. Involvement of brain opiate receptors in the immune-suppressive effect of morphine. Proc. Natl. Acad. Sci. USA 83:7114–7117.
Hendrickson, M., J. Shelby, J. J. Sullivan, and J. R. Saffle. 1989. Naloxone inhibits the in vivo immunosuppressive effects of morphine and thermal injury in mice. J. Burn Care Rehabil. 10:494–498.
Bayer, B. M., S. Daussin, M. Hernandez, and L. Irvin. 1990. Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism. Neuropharmacol. 29:369–374.
Bryant, H. U. and R. E. Roudebush. 1990. Suppressive effects of morphine pellet implants on in vivo parameters of immune function. J. Pharmacol. Exp. Ther. 255:410–414.
Eisenstein, T. K., J. J. Meissler, Jr., E. B. Geller, and M. W. Adler. 1990. Immunosuppression to tetanus toxoid induced by implanted morphine pellets. Ann. N. Y. Acad. Sci. 594:377–379.
Yeager, M. P., C. T. Yu, A. S. Campbell, M. Moschella, and P. M. Guyre. 1992. Effect of morphine and b-endorphin on human Fc receptor-dependent and natural killer cell functions. Clin. Immunol. Immunopathol. 62:336–343.
Lysle, D. T., M. E. Coussons, V. J. Watts, E. H. Bennett, and L. A. Dykstra. 1993. Morphine-induced alterations of immune status: Dose dependency, compartment specificity and antagonism by naltrexone. J. Pharmacol. Exp. Ther. 265:1071–1078.
Carpenter, G. W., L. Breeden, and D. J. J. Carr. 1995. Acute exposure to morphine suppresses cytotoxic T-lymphocyte activity. Int. J. Immunopharmacol. 17:1001–1006.
Lewis, J. W., Y. Shavit, G. W. Terman, R. P. Gale, and J. C. Liebeskind. 1983 ?1984. Stress and morphine affect survival of rats challenged with a mammary ascites tumor (MAT 13762B). Nat. Immun. Cell Growth Regul. 3:43–50.
Chao, C. C., B. M. Sharp, C. Pomeroy, G. A. Filice, and P. K. Peterson. 1990. Lethality of morphine in mice infected with Toxoplasma gondii. J. Pharmacol. Exp. Ther. 252:605–609.
Ishikawa, M., K. Tanno, A. Kamo, Y. Takayanagi, and K. Sasaki. 1993. Enhancement of tumor growth by morphine and its possible mechanism in mice. Biol. Pharm. Bull. 16:762–766.
Veyries, M.-L., M. Sinet, B. Desforges, and B. Rouveix. 1995. Effects of morphine on the pathogenesis of murine Friend retrovirus infection. J. Pharmacol. Exp. Ther. 272:498–504.
Page, G. G., S. Ben-Eliyahu, and J. C. Liebeskind. 1994. The role of LGL ?NK cells in surgery-induced promotion of metastasis and its attenuation by morphine. Brain Behav. Immun. 8:241–250.
Brown, J. H., J. W. Kissel, and P. M. Lish. 1968. Studies on the acute inflammatory response. I. Involvement of the central nervous system in certain models of inflammation. J. Pharmacol. Exp.Ther. 160:231–242.
Yonehara, N., Y. Iami, and R. Inoki. 1988. Effects of opioids on the heat stimulus-evoked substance P release and thermal edema in the rat hind paw. Eur. J. Pharmacol. 151:381–387.
Joris, J., A. Costello, R. Dubner, and K. M. Hargreaves. 1990. Opiates suppress crrageenan-induced edema and hyperthermia at doses that inhibit hyperalgesia. Pain 43:95–103.
Hong, Y. and F. V. Abbott. 1995. Peripheral opioid modulation of pain and inflammation in the formalin test. Eur. J. Pharmacol. 277:21–28.
Nelson, C. J., T. How, and D. T. Lysle. 1999. Enhancement of the contact hypersensitivity reaction by acute morphine administration at the elicitation phase. Clin. Immunol. 93:176–183.
Perrot, S., G. Guilbaud, and V. Kayser. 1999. Effects of intraplantar morphine on paw edema and pain-related behaviour in a rat model of repeated acute inflammation. Pain 83:249–257.
Eisenstein, T. K. and M. E. Hilburger. 1998. Opioid modulation of immune responses: Effects on phagocytic and lymphoid cell populations. J. Neuroimmunol. 83:36–44.
Mellon, R. D. and B. M. Bayer. 1998. Evidence for central opioid receptors in the immunomodulatory effects of morphine: Review of potential mechanism(s) of action. J. Neuroimmunol. 83:19–28.
Glasel, J. A. 2000. The effects of morphine on cell proliferation. Prog. Drug Res. 55:33–80.
Elliott, G. R., M. J. van Batenburg, and M. R. Dzoljic. 1987. Enhanced prostaglandin E2 and thromboxane B2 release from resident peritoneal macrophages isolated from morphine-dependent rats. FEBS Lett. 217:6–10.
Fecho, K., K. A. Maslonek, M. E. Coussons-Read, L. A. Dykstra, and D. T. Lysle. 1994. Macrophage-derived nitric oxide is involved in the depressed concanavalin A responsiveness of splenic lymphocytes from rats administered morphine in vivo. J. Immunol. 152:5845–5852.
Pacifici, R., G. Patrini, I. Venier, D. Parolaro, P. Zuccaro, and E. Gori. 1994. Effect of morphine and methadone acute treatment on immunological activity in mice: Pharmacokinetic and pharmacodynamic correlates. J. Pharmacol. Exp. Ther. 269:1112–1116.
Di Francesco, P., B. Tavazzi, R. Gaziano, G. Lazzarino, I. A. Casalinuovo, D. Di Pierro, and E. Garaci. 1998. Differential effects of acute morphine administrations on polymorphonuclear cell metabolism in various mouse strains. Life Sci. 63:2167–2174.
Chadzinska, M., E. Kolaczkowska, R. Seljelid, and B. Plytycz. 1999. Morphine modulation of peritoneal inflammation in Atlantic salmon and CB6 mice. J. Leukoc. Biol. 65:590–596.
Green, A. P., F. Mangan, and J. E. Ormerod. 1980. Induction of cell infiltration and acid hydrolase release into the peritoneal cavity of mice. Inflammation 4:205–213.
Baron, E. J. and R. A. Proctor. 1982. Elicitation of peritoneal polymorphonuclear neutrophils from mice. J. Immunol. Methods 49:305–313.
Beelen, R. H. J. and W. S. Walker. 1983. Dynamics of cytochemically distinct subpopulations of macrophages in elicited rat peritoneal exudates. Cell. Immunol. 82:246–257.
Qureshi, R. and B. A. Jakschik. 1988. The role of mast cells in thioglycollate-induced inflammation. J. Immunol. 141:2090–2096.
Abe, M., T. Goya, N. Nagata, H. Takahashi, H. Muranishi, and N. Shigematsu. 1992. Time-dependent alterations of leukotriene production and catabolism in rat peritoneal macrophages following intraperitoneal injection of thioglycollate broth. Prostaglandins, Leukotrienes and Essential Fatty Acids 45:59–65.
Kuziel, W. A., S. J. Morgan, T. C. Dawson, S. Griffin, O. Smithies, K. Ley, and N. Maeda. 1997. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc. Natl. Acad. Sci. USA 94:12053–12058.
Mizgerd, J. P., H. Kubo, G. J. Kutkoski, S. D. Bhagwan, K. Scharffeter-Kochanek, A. L. Beaudet, and C. M. Doerschuk. 1997. Neutrophil emigration in the skin, lungs, and peritoneum: Different requirements for CD11 ?CD18 revealed by CD18-deficient mice. J. Exp. Med. 186:1357–1364.
Robinson, A. P., T. M. White, and D. W. Mason. 1986. Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies, MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3. Immunol. 57:239–247.
van Goor, H., V. Fidler, J. J. Weening, and J. Grond. 1991. Determinations of focal and segmental glomerulosclerosis in the rat after renal ablation. Lab. Invest. 64:754–765.
Clark, W. M., J. D. Lauten, N. Lessov, W. Woodward, and B. M. Coull. 1995. Time course of ICAM-1 expression and leukocyte subset infiltration in rat forebrain ischemia. Mol. Chem. Neuropathol. 26:213–230.
Chen, B., T. Chou, and L. Sensenbrenner. 1993. Induction of murine peritoneal macrophage colony-forming cells by peritoneal administration of macrophage inflammatory protein-1. Exp. Hemat. 21:1591–1596.
Rhodes, N. P., J. A. Hunt, and D. F. Williams. 1997. Macrophage subpopulation differentiation by stimulation with biomaterials. J. Biomed. Mater. Res. 37:481–488.
Smith, C. W. 1993. Leukocyte-endothelial cell interactions. Semin. Hematol. 30:45–53.
Fecho, K. and P. L. Cohen. 1998. Fas ligand (gld)-and fas (lpr)-deficient mice do not show alterations in the extravasation or apoptosis of inflammatory neutrophils. J. Leuk. Biol. 64:373–383.
Herz, A. 1995. Role of immune processes in peripheral opioid analgesia. Adv. Exp. Med. Biol. 373:193–199.
Stanfa, L. and A. Dickenson. 1995. Spinal opioid systems in inflammation. Inflammation Res. 44:231–241.
Planas, M. E., L. Rodriguez, S. Sanchez, O. Pol, and M. M. Puig. 1995. Pharmacological evidence for the involvement of the endogenous opioid system in the response to local inflammation in the rat paw. Pain 60:67–71.
Rittner, H. L., A. Brack, H. Machelska, S. A. Mousa, M. Bauer, M. Schäfer, and C. Stein. 2001. Opioid peptide-expressing leukocytes. Anesthesiology 95:500–508.
Simpkins, C. O., C. A. Dickey, and M. P. Fink. 1984. Human neutrophil migration is enhanced by beta-endorphin. Life Sci. 34:2251–2255.
Marcoli, M., G. Ricevuti, A. Mazzone, M. Bekkering, S. Lecchini, and G. M. Frigo. 1988. Opioid-induced modification of granulocyte function. Int. J. Immunopharmacol. 10:425–433.
Grimm, M. C., A. Ben-Baruch, D. D. Taub, O. M. Z. Howard, J. H. Resau, J. M. Wang, H. Ali, R. Richardson, R. Snyderman, and J. J. Oppenheim. 1998. Opiates transdeactivate chemokine receptors: and opiate receptor-mediated heterologous desensitization. J. Exp. Med. 188:317–325.
Kromer, W. 1988. Endogenous and exogenous opioids in the control of gastrointestinal motility and secretion. Pharmacol. Rev. 40:121–162.
Hilburger, M. E., M. W. Adler, A. L. Truant, J. J. Meissler, Jr., V. Satishchandran, T. J. Rogers, and T. K. Eisenstein. 1997. Morphine induces sepsis in mice. J. Infect. Dis. 176:183–188.
Moss, J., N. R. Fahmy, N. Sunder, and M. A. Beaven. 1981. Hormonal and hemodynamic profile of an anaphylactic reaction in man. Circulation 63:210–213.
Rosow, C. E., J. Moss, D. M. Philin, and J. J. Savarese. 1982. Histamine release during morphine and fentanyl anesthesia. Anesthesiology 56:93–96.
Stellato, C., R. Cirillo, A. De Paulis, V. Casolaro, V. Patella, P. Mastronardi, B. Mazzarella, and G. Marone. 1992. Human basophil ?mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release. Anesthesiology 77:932–940.
Lopker, A., L. G. Abood, W. Hoss, and F. J. Lionetti. 1980. Stereoselective muscarinic acetylcholine and opiate receptors in human phagocytic leukocytes. Biochem. Pharmacol. 29:1361–1365.
Makman, M. H., T. V. Bilfinger, and G. B. Stefano. 1995. Human granulocytes contain an opiate alkaloid-selective receptor mediating inhibition of cytokine-induced activation and chemotaxis. J. Immunol. 154:1323–1330.
Stefano, F. B., P. Melchiorri, L. Negri, T. K. Hughes, Jr., and B. Scharrer. 1992. [D-Ala2]-Deltorphin I binding and pharmaco logical evidence for a special subtype of d opioid receptor on human and invertebrate immune cells. Proc. Natl. Acad. Sci. USA 89:9316–9320.
Magazine, H. I., Y. Liu, T. V. Bilfinger, G. L. Fricchione, and G. B. Stefano. 1996. Morphine-induced conformational changes in human monocytes, granulocytes, and endothelial cells and in invertebrate immunocytes and microglia are mediated by nitric oxide. J. Immunol. 156:4845–4850.
Kolb, H. and V. Kolb-Bachofen. 1992. Nitric oxide: A pathogenetic factor in autoimmunity. Immunol. Today 13:157–160.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fecho, K., Lysle, D.T. Morphine-Induced Enhancement in the Granulocyte Response to Thioglycollate Administration in the Rat. Inflammation 26, 259–271 (2002). https://doi.org/10.1023/A:1021408500630
Issue Date:
DOI: https://doi.org/10.1023/A:1021408500630